We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AKER:EURONEXT OSLOAker ASA Class A Analysis

Data as of 2026-05-24 - not real-time

NOK 351.60

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Aker BP’s share price of 351.6 NOK sits above the 20‑day and 50‑day SMAs (≈350 and 343) and the MACD histogram remains positive, indicating a short‑term bullish bias. However, the stock trades at a trailing P/E of 41.7× versus an industry average of 21.6×, and the DCF‑derived fair value of ≈86.9 NOK suggests the market is heavily pricing in future growth. The dividend yield looks attractive at 7.1%, but a payout ratio above 279% and negative free cash flow raise sustainability concerns. Recent news highlights stable Q1 production, a 97% efficiency rate, and the Symra field reaching first oil nine months ahead of schedule, bolstering the operational outlook.
From a fundamentals perspective, revenue is down modestly, leverage is high with a debt‑to‑equity near 85%, and forward earnings are expected to surge (forward EPS > 25 NOK), compressing the forward P/E to about 13.6×. Analyst consensus targets around 322 NOK are below current levels, implying modest downside potential. Combined with elevated 30‑day volatility (~43%) and a negative beta, the stock presents a mixed risk‑reward profile: upside is limited in the near term, but long‑term growth catalysts and a potential re‑rating could make it attractive at lower valuations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with limited upside
  • Current valuation far above DCF and peers
  • High dividend payout ratio questions sustainability

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable production and ahead‑of‑schedule project deliveries
  • Forward earnings growth compressing forward P/E
  • Elevated leverage and negative free cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term North Sea development pipeline
  • Potential de‑leveraging as cash flow improves
  • Attractive forward valuation relative to earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin5.31%
P/E Ratio41.7
ROE4.75%
ROA9.21%
Debt/Equity84.63
P/B Ratio2.1
Op. Cash FlowNOK6.9B
Free Cash FlowNOK-2700312576
Industry P/E21.6

Technical Analysis

TrendBullish
RSI52.7
SupportNOK 320.30
ResistanceNOK 373.80
MA 20NOK 350.14
MA 50NOK 342.93
MA 200NOK 280.31
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair ValueNOK 86.87
Target PriceNOK 320.11
Upside/Downside-8.96%
GradeOvervalued
TypeBlend
Dividend Yield7.14%

Risk Assessment

Beta-0.28
Volatility43.44%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.